It has been suggested that the advantages of inhibiting XIAP outweigh those of antagonizing any other IAPs for several reasons: (1) High abnormal expression of XIAP has been linked to poor prognosis of several types of cancers, including colon cancer, bladder cancer, breast cancer and others. Here, XIAP is linked to urinary bladder carcinoma.